Page last updated: 2024-10-22

amobarbital and Chagas Disease

amobarbital has been researched along with Chagas Disease in 2 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Titto, EH1
Cardoni, RL2
Rimoldi, MT1
de Bracco, MM1

Other Studies

2 other studies available for amobarbital and Chagas Disease

ArticleYear
Trypanosoma cruzi: parasite-induced release of lysosomal enzymes by human polymorphonuclear leukocytes.
    Experimental parasitology, 1983, Volume: 56, Issue:2

    Topics: Amobarbital; Azides; Chagas Disease; Cyanides; Cytochalasin B; Glucuronidase; Humans; Muramidase; Ne

1983
Antibody-dependent cytotoxicity of human and mouse mononuclear cells against Trypanosoma cruzi epimastigotes.
    Cellular immunology, 1984, Volume: 86, Issue:2

    Topics: Amitrole; Amobarbital; Animals; Antibody-Dependent Cell Cytotoxicity; Azides; Cell Adhesion; Chagas

1984